New Zolgensma data demonstrate age-appropriate development when used early, real-world benefit in older children and durability 5+ years post-treatment Read more
Aurinia Announces Positive Cost-Effectiveness Assessment of LUPKYNIS (voclosporin) in Latest ICER Draft Evidence Report Read more
Explore opportunities and strategies for convergence in the combination products space at Pre-Filled Syringes East Coast 2021 Read more
HepaTx, Namocell, and Takara Bio USA complete second phase of collaboration on single cell analysis for cell therapy to treat late-stage liver diseases Read more
Novavax Confirms High Levels of Efficacy Against Original and Variant COVID-19 Strains in United Kingdom and South Africa Trials Read more
PhaseBio Pharmaceuticals and BioVectra Enter into Supply Agreement to Support Development and Commercialization of Bentracimab Read more
Orgenesis Enters Second Phase of Collaboration with Hospital Infantil Universitario Niño Jesús in Madrid with Exclusive License to Commercialize Celyvir Solid Tumor Therapy Read more
Complix Signs Global Drug Discovery and Development Agreement with I-Mab to Develop Cell Penetrating Alphabodies against Two Intracellular Immuno-oncology Targets Read more
Lynne Ensor, Parexel Chair of SMi’s 4th Annual Pharmaceutical Microbiology East Coast Conference, exclusive interview released Read more